Elranatamab
Drug timelines are a Plus or Pro feature.
42 regulatory and trial events tracked for Elranatamab, covering 2023-10-25 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis [Phase 2]